These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19750235)

  • 1. Long-acting injectable risperidone as an option in first-episode psychosis.
    Covell NH
    Evid Based Ment Health; 2016 May; 19(2):e8. PubMed ID: 27073212
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of early and proactive use of long-acting injectable antipsychotics in the management of schizophrenia.
    Takeuchi H
    Int Clin Psychopharmacol; 2023 May; 38(3):182-183. PubMed ID: 36866848
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of low-frequency rTMS combined with risperidone on the gut microbiome in hospitalized patients with chronic schizophrenia.
    Li R; Fu R; Cui ZQ; Guo L; Chen YH; Bai J; Yang JB; Tan QR; Peng ZW
    Brain Res; 2023 Nov; 1819():148539. PubMed ID: 37598899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More options, more value: a new long-acting injectable formulation of risperidone.
    Takeuchi H
    Lancet Psychiatry; 2023 Dec; 10(12):911-913. PubMed ID: 37924832
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatotoxicity to Risperidone.
    André RT; Romão JP; Rebelo MS; Pais FC; Fernandes AM; Baronet PM; Abreu MN
    Prim Care Companion CNS Disord; 2024 Mar; 26(2):. PubMed ID: 38579255
    [No Abstract]   [Full Text] [Related]  

  • 6. A Rare Case of Risperidone Induced Reticular Palmar Pigmentation.
    Saha B; Gupta I; Dayal S; Chhabra S
    Indian Dermatol Online J; 2021; 12(1):183-184. PubMed ID: 33768051
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone-induced skin rash.
    Janardhana P; Nagaraj AK; Basavanna PL
    Indian J Psychiatry; 2016; 58(1):106-7. PubMed ID: 26985120
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of atypical antipsychotics in the elderly: a clinical review.
    Gareri P; Segura-García C; Manfredi VG; Bruni A; Ciambrone P; Cerminara G; De Sarro G; De Fazio P
    Clin Interv Aging; 2014; 9():1363-73. PubMed ID: 25170260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone long-acting injection: safety and efficacy in elderly patients with schizophrenia.
    Catalán R; Penadés R
    J Cent Nerv Syst Dis; 2011; 3():95-105. PubMed ID: 23861642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection.
    El-Hage W; Surguladze SA
    Neuropsychiatr Dis Treat; 2010 Sep; 6():455-64. PubMed ID: 20856609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting injectable risperidone.
    Ehret MJ; Fuller MA
    Ann Pharmacother; 2004 Dec; 38(12):2122-7. PubMed ID: 15522979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.
    Möller HJ
    Drugs; 2007; 67(11):1541-66. PubMed ID: 17661527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia.
    Singh D; O'Connor DW
    Clin Interv Aging; 2009; 4():351-5. PubMed ID: 19750235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.